COUGH MIXTURE

Main information

  • Trade name:
  • POTTIE'S COUGH MIXTURE
  • Pharmaceutical form:
  • ORAL SOLUTION/SUSPENSION
  • Units in package:
  • 500mL
  • Class:
  • Veterinary Medicine
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • SYKES VET

Documents

Localization

  • Available in:
  • POTTIE'S COUGH MIXTURE
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • CATTLE | HORSE | HORSE - YEARLING | PONY | BEEF | BOS INDICUS | BOS TAURUS | BOVINE | BUFFALO | BULL | BULLOCK | CALF | COLT | C
  • Therapeutic area:
  • expectorant,cough suppres
  • Therapeutic indications:
  • COUGH SUPPRESSION | BRONCHITIS | BRONCHODILATION | COUGH SUPPRESSANTS | DECONGESTANTS | EXPECTORANTS | MUCOID SECRETIONS | MUCOLYTICS | RESPIRATORY CONDITIONS | SINUSITIS
  • Product summary:
  • To relieve coughing in horses and cattle.

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Registered and available
  • Authorization number:
  • 35912/0500
  • Authorization date:
  • 24-05-2000
  • Last update:
  • 15-06-2017

Patient Information leaflet: composition, indications, side effects, dosage, interactions, adverse reactions, pregnancy, lactation

Pottie's

Cough

Mixture

LV34/4/00

Label for 500mL Bottle (Immediate Container) - Text Only

Front Panel

ANIMAL TREATMENT ONLY

Pottle's

Cough Mixture

Back Panel

SHAKE

WELL

BEFORE USE

30mL

15mL

45mL

Active Constituents

Ammonium Chloride

Extract

Liquorice

Extract

Squill

Extract

Ginger

To relieve Coughing

in Horses and Cattle

500mL

NRA 359121

c:;Q

107gIL

80gIL

27mLIL

27mLIL

DIRECTIONS

Dose

three

times daily by

mouth

Dose

Range:

Adult

Horse

Yearling

Pony

Cattle

WITHHOLDING

PERIODS:

CATTLE AND HORSES: NIL

DISPOSAL

Wrap

empty container in paper and

dispose in garbage

STORE

BEWW

25·C

Batch

Expiry

Date

Blue

Cross

Veterinary

Products

Livermores Lane, Manildra

2865

---------

N.R.A.

APPROVED

LABEL

(TEXT)

Label

.:3..'§.'i.!.~./.~.~P9.

..

Date

..

.(2f+

I.f?~

Signature~~<~!?W"

18-12-2018

Enovachem Pharmaceuticals Issues Voluntary Nationwide Recall of Dyural-40 and Dyural-80 Convenience Kits Containing Recalled Sodium Chloride Injection, USP, 0.9% Due to Latex Hazard

Enovachem Pharmaceuticals Issues Voluntary Nationwide Recall of Dyural-40 and Dyural-80 Convenience Kits Containing Recalled Sodium Chloride Injection, USP, 0.9% Due to Latex Hazard

Torrance, CA, Asclemed USA Inc is voluntarily recalling 20 lots of Dyural-40 and 61 lots of Dyural-80, to the user level. The products include recalled Sodium Chloride, USP, 0.9% manufactured by Fresenius Kabi, which has been recalled due to product labeling incorrectly stating stoppers do not contain latex.

FDA - U.S. Food and Drug Administration

4-12-2018

Mylan Expands Its Voluntary Nationwide Recall of Valsartan Tablets, USP, Amlodipine and Valsartan Tablets, USP, and Valsartan and Hydrochlorothiazide Tablets, USP, to all Lots Within Expiry Due to The Detection of Trace Amounts of NDEA (N-Nitrosodiethylam

Mylan Expands Its Voluntary Nationwide Recall of Valsartan Tablets, USP, Amlodipine and Valsartan Tablets, USP, and Valsartan and Hydrochlorothiazide Tablets, USP, to all Lots Within Expiry Due to The Detection of Trace Amounts of NDEA (N-Nitrosodiethylam

– Mylan N.V. (NASDAQ: MYL) today announced that its U.S. based Mylan Pharmaceuticals business is expanding its consumer-level voluntary nationwide recall to include all lots of Valsartan-containing products within expiry. The 104 additional lots include 26 lots of Amlodipine and Valsartan Tablets, USP (including the 5mg/160mg, 10mg/160mg, 5mg/320mg and 10mg/320mg strengths), 51 lots of Valsartan Tablets, USP (including 40 mg, 80 mg, 160 mg and 320 mg strengths), and 27 lots of Valsartan and Hydrochloroth...

FDA - U.S. Food and Drug Administration

28-9-2018

Peer review of the pesticide risk assessment of the active substance ABE‐IT 56 (components of lysate of Saccharomyces cerevisiae strain DDSF623)

Peer review of the pesticide risk assessment of the active substance ABE‐IT 56 (components of lysate of Saccharomyces cerevisiae strain DDSF623)

Published on: Thu, 27 Sep 2018 00:00:00 +0200 The conclusions of EFSA following the peer review of the initial risk assessments carried out by the competent authority of the rapporteur Member State, France, for the pesticide active substance ABE‐IT 56 (components of lysate of Saccharomyces cerevisiae strain DDSF623) are reported. The context of the peer review was that required by Regulation (EC) No 1107/2009 of the European Parliament and of the Council. The conclusions were reached on the basis of the...

Europe - EFSA - European Food Safety Authority Publications

24-7-2013

Danish Pharmacovigilance Update, 27 June 2013

Danish Pharmacovigilance Update, 27 June 2013

In this issue of Danish Pharmacovigilance Update: The benefits of medicines for the treatment of acne (Diane® Mite and others) continue to outweigh the risks of use within the indication.

Danish Medicines Agency

27-7-2018

EU/3/09/645 (Camurus AB)

EU/3/09/645 (Camurus AB)

EU/3/09/645 (Active substance: Octreotide chloride (lipid depot solution)) - Transfer of orphan designation - Commission Decision (2018)5047 of Fri, 27 Jul 2018 European Medicines Agency (EMA) procedure number: EMA/OD/010/09/T/03

Europe -DG Health and Food Safety

27-7-2018

EU/3/06/401 (Pfizer Europe MA EEIG)

EU/3/06/401 (Pfizer Europe MA EEIG)

EU/3/06/401 (Active substance: N-methyl D-(2,3,4,5,6-pentahydroxy-hexyl)-ammonium; 2-(3,5-dichloro-phenyl)-benzoxazole-6-carboxylate) - Transfer of orphan designation - Commission Decision (2018)5038 of Fri, 27 Jul 2018 European Medicines Agency (EMA) procedure number: EMA/OD/032/06/T/03

Europe -DG Health and Food Safety

27-6-2018

Darzalex (Janssen-Cilag International NV)

Darzalex (Janssen-Cilag International NV)

Darzalex (Active substance: daratumumab) - Centralised - Yearly update - Commission Decision (2018)4107 of Wed, 27 Jun 2018

Europe -DG Health and Food Safety